Tianeptine ‘Gas Station Heroin’ Raises Alarms as States Move to Ban Unapproved Drug
SEO lede: Tianeptine, commonly called ‘gas station heroin,’ is an unapproved opioid-like substance sold in convenience stores, gas stations and online under names like Neptune’s Fix — authorities warn it carries high addiction and overdose risks, including respiratory depression and death.
Key takeaways
- Unapproved and widely available: Tianeptine is not FDA-approved for sale in the U.S. yet appears in stores and online under brand names such as Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red.
- Opioid-like danger at high doses: In recreational quantities it stimulates mu-opioid receptors and can cause opioid-like addiction, respiratory depression and death.
- States moving to ban: Roughly a dozen states have taken steps to classify or ban tianeptine, with Connecticut recently adding it to Schedule I.
Key information
Tianeptine is a tricyclic antidepressant legally prescribed in parts of Europe, Asia and Latin America at controlled doses, but it is not approved by the U.S. Food and Drug Administration for sale in the United States. See FDA.
In the U.S., tianeptine appears in convenience stores, gas stations, vape shops and online as pills, powders, salts and liquids under brand names such as Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red — see Mayo Clinic.
At high recreational doses tianeptine acts on mu-opioid receptors and can be more potent than morphine, producing opioid-like addiction, respiratory depression and death (see FDA and VCU Health).
As of 2025, roughly a dozen states have moved to classify or ban tianeptine; Connecticut is the latest to add it to Schedule I. See state action and reporting at NJ Health Alert and the Democrats, House Energy & Commerce release.
What tianeptine is and how it works
Tianeptine’s clinical origin: Developed as an antidepressant, it is prescribed in parts of Europe, Asia and Latin America at low, controlled doses. At low doses it may affect serotonergic systems, but at much higher, unregulated doses it stimulates mu-opioid receptors — the same receptors targeted by heroin and many prescription opioids.
High-dose effects: That opioid-like action can produce euphoria, then tolerance, dependence and life‑threatening respiratory depression (see FDA, Mayo Clinic and NCBI).
Health risks and clinical reports
Medical authorities report a broad range of harms tied to misuse: agitation, confusion, drowsiness, sweating, nausea and vomiting, and more severe signs such as hypertension, tachycardia, respiratory depression, seizures, coma and death. Chronic misuse yields tolerance and opioid-like withdrawal with severe cravings, diarrhea and muscle pain.
“Poison control centers and the DEA have logged rising exposure calls and hospitalizations, including ICU clusters in states like New Jersey and Virginia.”
See cluster reports and clinical advisories: NJ Health Alert, VCU Health, and FDA.
Why these products spread in convenience stores
Sellers market tianeptine products as “dietary supplements,” nootropics or aids for pain, anxiety, depression and opioid withdrawal. Packaging often mimics candy or flavored products that appeal to young people. The FDA has repeatedly called these marketing claims false and warned that tianeptine has no approved U.S. use.
Product safety failures: Items labeled Neptune’s Fix and others have been recalled or flagged after tests showed contamination or the presence of additional dangerous substances. The lack of federal scheduling historically allowed rapid online distribution (see FDA and Mayo Clinic).
Legal moves at the state level and federal calls
Multiple states have acted to restrict or ban tianeptine; reporting indicates up to 14 states at various times have classified it as Schedule I or moved to ban sales. Connecticut recently added tianeptine to its restricted schedule alongside substances like kratom and nitazenes.
State officials cite addiction prevention and youth protection as reasons. At the federal level the FDA has issued emergency warnings and some clinicians and lawmakers are pushing for national regulation or scheduling because routine drug tests often miss tianeptine. See NJ Health Alert, FDA, and the Democrats, House Energy & Commerce release.
Expert concerns and frontline testimony
Emergency physicians and toxicologists report seeing patients who took high amounts seeking a quick high and required intensive support. Experts warn that mixing tianeptine with alcohol or other drugs increases the risk of slowed breathing and cardiac complications.
Recommendations from clinicians: Stronger regulation, improved public education, and clinician awareness so families and youth do not mistake these products for harmless supplements (see VCU Health and Mayo Clinic).
Public health response and resources
Federal and state agencies have issued safety alerts and urged removal of certain products. State health departments have released advisories and recalls when contaminated or mislabeled items are identified. Poison control centers recommend immediate reporting of exposures.
For those seeking help for addiction, SAMHSA National Helpline provides a 24/7 confidential resource for treatment referrals and support.
Investigative notes on product safety and testing
Testing has found variability in product content. Some Neptune’s Fix items were tainted with synthetic cannabinoids; others contained inconsistent tianeptine levels. That unpredictability makes dosing and risk uncertain. Routine workplace and clinical drug tests may not detect tianeptine reliably, complicating diagnosis and surveillance.
These testing and detection gaps helped the substance spread and contributed to high rates of misuse documented by poison centers and hospitals (see FDA and NJ Health Alert).
Implications for Alamogordo, New Mexico
Public safety and youth protection: Alamogordo is not immune to national retail and online trends. Convenience stores, gas stations and online sellers in Otero County could become distribution points. Local leaders and parents should watch for candy-flavored pills and unbranded supplements that target youth (FDA).
Law enforcement and local policy: Sheriff’s deputies and city officials may require guidance for enforcement if products appear locally. States and municipalities that have banned tianeptine offer models for local ordinances and retailer compliance checks (NJ Health Alert).
Healthcare and emergency services: Local clinics and hospitals should be briefed on recognition and treatment of tianeptine toxicity — including opioid-like respiratory depression and potential ICU needs. Poison control and SAMHSA resources are available for clinicians and families (SAMHSA National Helpline).
Economic and business considerations: Retailers unknowingly stocking dangerous products risk community backlash and legal exposure. Encouraging voluntary compliance with state law and retailer education can protect lawful business and public safety (Mayo Clinic).
Community and faith-based response: Churches, schools and civic groups can add tianeptine education to drug-prevention programs and connect families to treatment and support resources (VCU Health).
Practical steps for residents and officials
- Parents and guardians: Inspect medicine cabinets and be cautious about unbranded supplements or candy-like pills (FDA).
- Retailers: Review inventory and avoid stocking unapproved tianeptine products. Chambers of commerce and law enforcement can help inform store owners about legal and public-health risks (Democrats, House Energy & Commerce).
- Healthcare providers: Be aware routine drug screens may miss tianeptine; treatment can require opioid overdose protocols and supportive care. Consult poison control centers for suspected exposures (NJ Health Alert).
Sources and further reading
- U.S. Food and Drug Administration: “New ‘Gas Station Heroin’ Tianeptine Product Trend”
- Mayo Clinic: “Tianeptine — Is safe use possible?”
- Virginia Commonwealth University Health: “What you need to know about gas station heroin”
- New Jersey Health Alert (cluster report, 2024)
- Democrats, House Energy & Commerce Committee press release
- National Center for Biotechnology Information (NCBI) research summary
- Talbot Health on emerging substances
- SAMHSA National Helpline (treatment resources)
Dateline: WASHINGTON (Times Media Service)
